JOHANNES-PETER STASCH, DR.,PETER SANDNER,GEORGES VON DEGENFELD,SANDNER, PETER
申请号：
PT11701683
公开号：
PT2531187E
申请日:
2011.02.03
申请国别(地区):
PT
年份:
2015
代理人:
摘要：
The present invention relates to soluble guanylate cyclase (sGC) and to phosphodiesterases (PDEs) and the pharmacology of sGC stimulators, sGC activators and PDE inhibitors. More particularly, the invention relates to the use of sGC stimulators and sGC activators in combination with PDE5 inhibitors for preparation of medicaments for the treatment of Cystic Fibrosis (CF).
